The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma
The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma
批准号:
10584592
负责人:
Xiang Chen
金额:
$40.8万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-04 至 2027-02-28
关键词:
AdultAftercareArchivesBar CodesBayesian AnalysisBiopsyBiopsy SpecimenCell CycleCell NucleusCell SurvivalCellsCharacteristicsChildChildhoodChildhood RhabdomyosarcomaChildhood Solid NeoplasmChromatinClinicalCollaborationsComputer AnalysisDNA MethylationDataDevelopmentDiagnosisDisease remissionEnhancersEpigenetic ProcessEvaluationEwings sarcomaFormalinFreezingGene ExpressionGenesGenetic TranscriptionGenomicsGliomaGoalsGovernmentHematologic NeoplasmsHeterogeneityIndividualMachine LearningMalignant Childhood NeoplasmMalignant NeoplasmsMeasuresMesoderm CellMethodsModelingMolecularMonitorMorphologyMuscle CellsMyoblastsNetwork-basedNormal CellOrthopticsOutcomeParaffin EmbeddingParaxial MesodermPathway interactionsPatientsPersonsPilot ProjectsPopulationPositioning AttributeProductivityRare DiseasesRecurrenceRecurrent diseaseRecurrent tumorRelapseResearchResearch ProposalsResistanceRhabdomyosarcomaRiskRisk FactorsRisk ReductionRoleSaint Jude Children&aposs Research HospitalSamplingSkeletal MuscleSolidSpecimenTestingTissue-Specific Gene ExpressionTranslational Researchactivity markeranticancer researchbiomarker developmentchemotherapycomputerized toolsconvolutional neural networkdata miningdeep learningdisorder riskepigenomicsexperienceimprovedimproved outcomein vivoin vivo Modelinnovationleukemiamachine learning algorithmmethylation patternmethylomemultidisciplinarymyogenesisneoplastic cellnovelpatient derived xenograft modelpreservationprognostic significancepromoterprototypereconstitutionresponsesingle nucleus RNA-sequencingsingle-cell RNA sequencingsoft tissuetherapy resistanttranscriptome sequencingtranscriptomicstumortumor DNAtumor heterogeneity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
Rhabdomyosarcoma (RMS) is a devastating pediatric soft tissue cancer with morphological features of develop-
ing skeletal muscles. Although most patients with RMS achieve a complete remission, one third will develop
disease recurrence which is associated with a dismal clinical outcome. These clinical challenges underscore an
urgent need to identify patients at risk for resistance and develop better therapy to reduce the risk of recurrence.
Our pilot study revealed that rhabdomyosarcoma tumors have developmental intratumoral heterogeneity: differ-
ent cells in a single tumor harbor transcriptomic feature of different myogenic stages. Moreover, tumor cells with
developmentally immature characteristics are enriched in post-therapy specimens and have the potential to rep-
licate and reconstitute the entire developmental trajectory after therapy. In this application, we will develop com-
putational analysis methods to unambiguously identify immature tumor subpopulations in single cell RNA-seq
data and to reveal their master deregulated genes (Aim 1); In Aim 2, we will characterize the changes in those
transcriptional networks and cellular states during treatment in orthoptic patient derived xenograft models (O-
PDXs) in vivo. And in Aim 3, we will develop an innovative deep-learning data mining approach to evaluate the
prognostic significance of the myogenic transcriptional networks that underly RMS cellular heterogeneity in pa-
tient tumors. The proposed study integrates computational, statistical and experimental approaches to study the
role of immature cell populations in rhabdomyosarcoma recurrence. Building upon our computational expertise,
research experience in rhabdomyosarcoma, robust preliminary results and highly productive collaborations with
multi-disciplinary expertise in genomics/epigenomics, machine learning, Bayesian statistics and translational re-
search in rhabdomyosarcoma, we are in a unique position to achieve the goals of this research proposal. The
proposed research will be impactful because it will potentially change how we treat children with rhabdomyosar-
coma and the developed computational/statistical approaches will be broadly applicable to cancer research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA
-
批准号:10521711
-
项目类别:
-
资助金额:$69.14万
-
财政年份:2022
-
负责人:Xiang Chen
-
依托单位:
EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA
-
批准号:10649516
-
项目类别:
-
资助金额:$67.76万
-
财政年份:2022
-
负责人:Xiang Chen
-
依托单位:
The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma
-
批准号:10445963
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2022
-
负责人:Xiang Chen
-
依托单位:
海外基金